Resources - Scientific Posters

Rapid Screening of a Cell-based Assay for GLP-1 Receptor Using a Natural Product Library

Download

Related Products: Precision, Synergy Neo2

September 28, 2012



Authors: Brad Larson and Peter Banks, BioTek Instruments, Inc., Winooski, Vermont; Nicolas Pierre, Suzanne Graham, Jean-Luc Tardieu and Francois Degorce, Cisbio US, Inc., Bedford, Massachusetts

Cisbio

 

Introduction

 

Glucagon-like peptide-1 receptor (GLP-1R) is a G-protein coupled receptor that is present in insulin-secreting beta cells. Intact GLP-1(1-37) is produced by posttranslational processing of proglucagon precursor and converted into active forms of GLP-1 [(7-36) amide and (7-37)] with N-terminal truncation. Then, active forms of GLP-1 are deactivated by the further fragmentation with peptidases1,2.

Its defining action is augmentation of glucose-induced insulin secretion following intake of carbohydrates and lipids. It also inhibits glucagon secretion and food intake. For this reason, GLP-1R is an interesting target for type-2 diabetes intervention.

Here we will demonstrate the detection of GLP-1R binding through the incorporation of a homogeneous cell-based binding assay using Tag-lite® technology. The assay was automated using a non-contact liquid dispenser commonly used in highthroughput settings. Detection of the two fluorescent emissions was accomplished simultaneously using the matched PMTs of an HTS multi-mode microplate reader. Optimization experiments were performed to validate the proper conditions to use for automated assay processing. A small primary screen of natural products was then performed under high throughput screening conditions, followed by the creation of dose-response curves using known GLP-1R binders.

 

link

We use cookies to provide visitors of our website the best possible experience. If you continue without changing your browser settings, we'll assume you are happy to receive all cookies on the BioTek website. To learn more how we use cookies or how to block cookies, please visit our cookie policy.